Nonabine
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171846This classification denotes an antiemetic agent and antidepressant agent with the molecular formula C25H33NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 77DUK856J7, chemically known as 7-(1,2-dimethylheptyl)-2,2-dimethyl-4-(4-pyridyl)-2h-1-benzopyran-5-ol but generally known as nonabine, which bears US NIH Compound Identifier 71885. European Medicines Agency schedules Nonabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09348MIG. The term NONABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). NONABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nonabine under HS 29349990 and SITC 51579. As of Q4 2014, NONABINE remains the US FDA Preferred Term for this commodity. Nonabine bears US NLM identifiers UMLS ID C0132764 and NCI Concept Code C72950. SMILES: O1C(C=C(C2C1CC(C(C(CCCCC)C)C)CC2O)C1CCNCC1)(C)C.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.